Community-acquired pneumonia in adults;Ambulant erworbene Pneumonie bei Erwachsenen

Deutsche Medizinische Wochenschrift

Volumn 145, Issue 6, 2020, Pages 359-370

  Mikolajewska, Agata ^a   Witzenrath, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

algorithm; bioavailability; major and minor criteria; medical emergency; Pathogen spectrum

Indexed keywords

ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; MEDICAL INFORMATION; ADULT; AGED; COMMUNITY ACQUIRED INFECTION; GERMANY; HUMAN; MIDDLE AGED; PNEUMONIA; RISK FACTOR; VERY ELDERLY;

ANTIINFECTIVE AGENT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; GERMANY; HUMANS; MIDDLE AGED; PNEUMONIA; RISK FACTORS;

EID: 85082033320     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/a-0993-0874     Document Type: Article

References (20)

1. Kolditz M. Tesch F. Mocke L. et al Burden and risk factors of ambulantory or hospitalized CAP: A population based cohort study. Respir Med: 2016; 121 32 38. doi:10.1016/j.rmed.2016.10.015
2. Pletz M. W. Rohde G. Schutte H. et al Epidemiology and aetiology of community-acquired pneumonia (CAP). Dtsch Med Wochenschr: 2011; 136 775 780. doi:10.1055/s-0031-1275806
3. Zhou F. Wang Y. Liu Y. et al Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: A multicentre prospective registry study from the CAP-China Network. Eur Respir J: 2019; 54 1802406. doi: 0.1183/13993003.02406-2018
4. Moore M. Stuart B. Little P. et al Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study. Eur Respir J: 2017; 50 1700434. doi:10.1183/13993003.00434-2017
5. Claessens Y. E. Debray M. P. Tubach F. et al Early Chest Computed Tomography Scan to Assist Diagnosis and Guide Treatment Decision for Suspected Community-acquired Pneumonia. Am J Resp Crit Care Med: 2015; 192 974 982. doi:10.1164/rccm.201501-0017OC
6. Kolditz M. Ewig S. Schütte H. et al Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. J Intern Med: 2015; 278 193 202. doi:10.1111/joim.12349
7. Kolditz M. Braeken D. Ewig S. et al Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired Pneumonia. Semin Respir Crit Care Med: 2016; 37 886 896. doi:10.1055/s-0036-1592127
8. Metlay J. P. Waterer G. W. Long A. C. et al Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med: 2019; 200 e45 e67. doi:10.1164/rccm.201908-1581ST
9. Lepper P. M. Ott S. Nuësch E. et al Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: Prospective cohort study. BMJ: 2012; 344 e3397. doi:10.1136/bmj.e3397
10. Ewig S. Höffken G. Kern W. V. et al S3-Leitlinie: Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention-Update 2016. Pneumologie: 2016; 70 151 200. doi: 10.1055/s-0042-101873
11. Ferrer R. Martin-Loeches I. Phillips G. et al Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program. Crit Care Med: 2014; 42 1749 1755. doi:10.1097/CCM.0000000000000330
12. Nie W. Li B. Xiu Q. β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: A systematic review and meta-analysis. J Antimicrob Chemother: 2014; 69 1441 1446. doi:10.1093/jac/dku033
13. König R. Cao X. Oswald M. et al Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning. Eur Respir J: 2019; 10.1183/13993003.00824-2019
14. Stets R. Popescu M. Gonong J. R. et al Omadacycline for Community-Acquired Bacterial Pneumonia. N Engl J Med: 2019; 380 517 527. doi:10.1056/NEJMoa1800201
15. Barrera C. M. Mykietiuk A. Metev H. et al Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia (SOLITAIRE-ORAL). Lancet Infect Dis: 2016; 16 421 430. doi:10.1016/S1473-3099(16)00017-7
16. Frat J. P. Thille A. W. Girault C. et al High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. NEJM: 2015; 372 2185 2196. doi:10.1056/NEJMoa1503326
17. Brack M. C. Lienau J. Kuebler W. M. et al Cardiovascular sequelae of pneumonia. Curr Opin Pulm Med: 2019; 25 257 262. doi:10.1097/MCP.0000000000000584
18. Schuetz P. Müller B. Christ-Crain M. et al Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. CDS: 2017; 10 CD007498. doi:10.1002/14651858
19. Robert Koch Institut Empfehlungen der Ständigen Impfkommission beim Robert Koch-Institut-2019/2020, Epidemiologisches Bulletin Nr. 34. Stand: 29.01.2020; 22. August 2019. Im Internet: Www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Impfempfehlungen_node.htm
20. Baskaran V. Murray R. L. Hunter A. et al Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis. PLoS One: 2019; 14 e0220204. doi:10.1371/journal.pone.0220204